397 related articles for article (PubMed ID: 25887355)
1. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial.
Hempe JM; Liu S; Myers L; McCarter RJ; Buse JB; Fonseca V
Diabetes Care; 2015 Jun; 38(6):1067-74. PubMed ID: 25887355
[TBL] [Abstract][Full Text] [Related]
2. The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial.
van Steen SC; Schrieks IC; Hoekstra JB; Lincoff AM; Tardif JC; Mellbin LG; Rydén L; Grobbee DE; DeVries JH;
Eur J Prev Cardiol; 2017 May; 24(8):858-866. PubMed ID: 28186441
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE.
Klein KR; Franek E; Marso S; Pieber TR; Pratley RE; Gowda A; Kvist K; Buse JB
BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34819298
[TBL] [Abstract][Full Text] [Related]
4. Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial.
Miller ME; Williamson JD; Gerstein HC; Byington RP; Cushman WC; Ginsberg HN; Ambrosius WT; Lovato L; Applegate WB;
Diabetes Care; 2014; 37(3):634-43. PubMed ID: 24170759
[TBL] [Abstract][Full Text] [Related]
5. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
[TBL] [Abstract][Full Text] [Related]
6. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.
Bonds DE; Miller ME; Bergenstal RM; Buse JB; Byington RP; Cutler JA; Dudl RJ; Ismail-Beigi F; Kimel AR; Hoogwerf B; Horowitz KR; Savage PJ; Seaquist ER; Simmons DL; Sivitz WI; Speril-Hillen JM; Sweeney ME
BMJ; 2010 Jan; 340():b4909. PubMed ID: 20061358
[TBL] [Abstract][Full Text] [Related]
7. Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes.
Hsia DS; Rasouli N; Pittas AG; Lary CW; Peters A; Lewis MR; Kashyap SR; Johnson KC; LeBlanc ES; Phillips LS; Hempe JM; Desouza CV;
J Clin Endocrinol Metab; 2020 Mar; 105(3):e130-8. PubMed ID: 31965161
[TBL] [Abstract][Full Text] [Related]
8. Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
van Steen SC; Woodward M; Chalmers J; Li Q; Marre M; Cooper ME; Hamet P; Mancia G; Colagiuri S; Williams B; Grobbee DE; DeVries JH;
Diabetologia; 2018 Apr; 61(4):780-789. PubMed ID: 29308539
[TBL] [Abstract][Full Text] [Related]
9. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.
Miller ME; Bonds DE; Gerstein HC; Seaquist ER; Bergenstal RM; Calles-Escandon J; Childress RD; Craven TE; Cuddihy RM; Dailey G; Feinglos MN; Ismail-Beigi F; Largay JF; O'Connor PJ; Paul T; Savage PJ; Schubart UK; Sood A; Genuth S;
BMJ; 2010 Jan; 340():b5444. PubMed ID: 20061360
[TBL] [Abstract][Full Text] [Related]
10. Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial.
Basu S; Raghavan S; Wexler DJ; Berkowitz SA
Diabetes Care; 2018 Mar; 41(3):604-612. PubMed ID: 29279299
[TBL] [Abstract][Full Text] [Related]
11. Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients.
Østergaard HB; Mandrup-Poulsen T; Berkelmans GFN; van der Graaf Y; Visseren FLJ; Westerink J;
Diabetes Metab; 2019 Jun; 45(3):254-260. PubMed ID: 29784563
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.
Margolis KL; O'Connor PJ; Morgan TM; Buse JB; Cohen RM; Cushman WC; Cutler JA; Evans GW; Gerstein HC; Grimm RH; Lipkin EW; Narayan KM; Riddle MC; Sood A; Goff DC
Diabetes Care; 2014 Jun; 37(6):1721-8. PubMed ID: 24595629
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.
Chen YW; Wang JS; Sheu WH; Lin SY; Lee IT; Song YM; Fu CP; Lee CL
PLoS One; 2017; 12(2):e0171753. PubMed ID: 28182722
[TBL] [Abstract][Full Text] [Related]
14. Concordance the hemoglobin glycation index with glycation gap using glycated albumin in patients with type 2 diabetes.
Kim MK; Jeong JS; Kwon HS; Baek KH; Song KH
J Diabetes Complications; 2017 Jul; 31(7):1127-1131. PubMed ID: 28487124
[TBL] [Abstract][Full Text] [Related]
15. Association between Inflammation and Biological Variation in Hemoglobin A1c in U.S. Nondiabetic Adults.
Liu S; Hempe JM; McCarter RJ; Li S; Fonseca VA
J Clin Endocrinol Metab; 2015 Jun; 100(6):2364-71. PubMed ID: 25867810
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Hemoglobin Glycation Index Measured by Continuous Glucose Monitoring With Complications in Type 1 Diabetes.
Ibarra-Salce R; Pozos-Varela FJ; Martinez-Zavala N; Lam-Chung CE; Mena-Ureta TS; Janka-Zires M; Faradji RN; Madrigal-Sanroman JR; de la Garza-Hernandez NE; Almeda-Valdes P
Endocr Pract; 2023 Mar; 29(3):162-167. PubMed ID: 36627022
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Long-term HbA
Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
[TBL] [Abstract][Full Text] [Related]
18. Association between the haemoglobin glycation index (HGI) and clinical outcomes in patients with acute decompensated heart failure.
Cheng W; Huang R; Pu Y; Li T; Bao X; Chen J; Li G; Wu H; Wei Z
Ann Med; 2024 Dec; 56(1):2330615. PubMed ID: 38513606
[TBL] [Abstract][Full Text] [Related]
19. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Gerstein HC; Riddle MC; Kendall DM; Cohen RM; Goland R; Feinglos MN; Kirk JK; Hamilton BP; Ismail-Beigi F; Feeney P;
Am J Cardiol; 2007 Jun; 99(12A):34i-43i. PubMed ID: 17599423
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study.
Sakane N; Hirota Y; Yamamoto A; Miura J; Takaike H; Hoshina S; Toyoda M; Saito N; Hosoda K; Matsubara M; Tone A; Kawashima S; Sawaki H; Matsuda T; Domichi M; Suganuma A; Sakane S; Murata T
J Diabetes Investig; 2023 Apr; 14(4):582-590. PubMed ID: 36789495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
